What 4C Biomed say about themselves
“We focus on immune targets – the key to unlocking new and effective cancer therapies. Our unique and innovative platform identifies novel immune targets we”
“We focus on immune targets – the key to unlocking new and effective cancer therapies. Our unique and innovative platform identifies novel immune targets we”
Officer details are public data from the Companies House register.
People and entities with significant control, from the Companies House PSC register
Figures from 2022 accounts. Newer accounts, made up to 31 December 2024, are filed but not read yet. See them on Companies House
| 2022 | 2021 | 2020 | |
|---|---|---|---|
| Fixed Assets | £196,042 | USD 571,807 | USD 590,557 |
| Current Assets | £1,877,533 | USD 2,513,193 | |
| Debtors | £1,506,169 | USD 1,274,299 | USD 1,142,086 |
| Cash | £371,364 | USD 1,238,894 | |
| Creditors (< 1 year) | £535,924 | USD 467,123 | USD 424,619 |
| Creditors (> 1 year) | £0 | USD 740,908 | USD 740,908 |
| Net Current Assets | £1,341,609 | USD 2,046,070 | USD 717,467 |
| Net Assets | £1,456,010 | USD 1,858,862 | USD 567,116 |
| Shareholder Funds | £1,456,010 | USD 1,858,862 | USD 567,116 |
Filing history not loaded yet. See it on Companies House
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →